Studies of Prabhu et al. [76] conducted on patient-derived glioma specimens showed the accumulation of cysteine sulfinic acid (a product of reaction catalyzed by CDO1) in glioblastoma; CSA was identified as one of the main metabolites differentiating glioblastoma from low-grade glioma. The gene discussed is CDO1; the disease is glioma.